Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile

References

• CooperGMChapter 2: classification and development of neoplasmsElements of Human CancerBurlington, MAJones and Bartlett Publishers Inc19921530
   Google Scholar
• Canadian Cancer SocietyCanadian Cancer StatisticsToronto, ONCanadian Cancer Society2015
   Google Scholar
• ChidambaramMManavalanRKathiresanKNanotherapeutics to overcome conventional cancer chemotherapy limitationsJ Pharm Pharm Sci2011141677721501554
   PubMed Web of Science ®Google Scholar
• MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumortargeted drug delivery based on EPR-effectEur J Pharm Biopharm200971340941919070661
   PubMed Web of Science ®Google Scholar
• FengS-SChienSChemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChem Eng Sci2003581840874114
   Web of Science ®Google Scholar
• GelderblomHVerweijJNooterKSparreboomACremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer200137131590159811527683
   PubMed Web of Science ®Google Scholar
• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm20022351–217919211879753
   PubMed Web of Science ®Google Scholar
• BerghMMagnussonKNilssonJLKarlbergATContact allergenic activity of Tween 80 before and after air exposureContact Dermatitis19973719189255480
   PubMedGoogle Scholar
• HerbstRSKhuriFRMode of action of docetaxel – a basis for combination with novel anticancer agentsCancer Treat Rev200329540741512972359
   PubMed Web of Science ®Google Scholar
• ZhaoPAstrucDDocetaxel nanotechnology in anticancer therapyChemMedChem20127695297222517723
   PubMed Web of Science ®Google Scholar
• TakimotoCBeeramMMicrotubule stabilizing agents in clinical oncology, the taxanesFojoTThe Role of Microtubules in Cell Biology, Neurobiology, and OncologyTotowa, NJHuman Press2008395419
   Google Scholar
• HittRRodríguezCDocetaxelSchwabMEncyclopedia of CancerBerlinSpringer-Verlag201111481150
   Google Scholar
• van ZuylenLVerweijJSparreboomARole of formulation vehicles in taxane pharmacologyInvest New Drugs200119212514111392447
   PubMed Web of Science ®Google Scholar
• ten TijeAJVerweijJLoosWJSparreboomAPharmacological effects of formulation vehicles: implications for cancer chemotherapyClin Pharmacokinet200342766568512844327
   PubMed Web of Science ®Google Scholar
• SannaVRoggioAMPosadinoAMNovel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studiesNanoscale Res Lett20116126021711774
   PubMed Web of Science ®Google Scholar
• BlancoEHsiaoAMannAPLandryMGMeric-BernstamFFerrariMNanomedicine in cancer therapy: innovative trends and prospectsCancer Sci201110271247125221447010
   PubMed Web of Science ®Google Scholar
• HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833
   PubMed Web of Science ®Google Scholar
• ContiMTazzariVBacciniCPerticiGSerinoLPDe GiorgiUAnticancer drug delivery with nanoparticlesIn vivo2006206A69770117203748
   PubMedGoogle Scholar
• ChoKWangXNieSChenZGShinDMTherapeutic nano-particles for drug delivery in cancerClin Cancer Res20081451310131618316549
   PubMed Web of Science ®Google Scholar
• JabirNRTabrezSAshrafGMShakilSDamanhouriGAKamalMANanotechnology-based approaches in anticancer researchInt J Nanomedicine201274391440822927757
   PubMed Web of Science ®Google Scholar
• DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
   PubMed Web of Science ®Google Scholar
• HamidiMAzadiARafieiPAshrafiHA pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approachCrit Rev Ther Drug Carrier Syst201330543546724099328
   PubMed Web of Science ®Google Scholar
• SongXZhaoXZhouYLiSMaQPharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticlesCurr Drug Metab2010111085986921208172
   PubMedGoogle Scholar
• RafieiPMichelDHaddadiAApplication of a rapid ESI–MS/MS method for quantitative analysis of docetaxel in polymeric matrices of PLGA and PLGA–PEG nanoparticles through direct injection to mass spectrometerAm J Anal Chem20156164175
   Google Scholar
• MoghimiSMHunterACAndresenTLFactors controlling nanoparticle pharmacokinetics: an integrated analysis and perspectiveAnnu Rev Pharmacol Toxicol20125248150322035254
   PubMed Web of Science ®Google Scholar
• ToyRHaydenEShoupCBaskaranHKarathanasisEThe effects of particle size, density and shape on margination of nanoparticles in microcirculationNanotechnology2011221111510121387846
   PubMed Web of Science ®Google Scholar
• RaoJShedding light on tumors using nanoparticlesACS Nano20082101984198619206441
   PubMed Web of Science ®Google Scholar
• KircherMFMahmoodUKingRSWeisslederRJosephsonLA multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineationCancer Res200363238122812514678964
   PubMed Web of Science ®Google Scholar
• Owens IiiDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMedGoogle Scholar
• YooJWChambersEMitragotriSFactors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospectsCurr Pharm Des201016212298230720618151
   PubMed Web of Science ®Google Scholar
• WangJSuiMFanWNanoparticles for tumor targeted therapies and their pharmacokineticsCurr Drug Metab201011212914120359289
   PubMedGoogle Scholar
• ZhangJSLiuFHuangLImplications of pharmacokinetic behavior of lipoplex for its inflammatory toxicityAdv Drug Deliv Rev200557568969815757755
   PubMed Web of Science ®Google Scholar
• CedervallTLynchIFoyMDetailed identification of plasma proteins adsorbed on copolymer nanoparticlesAngew Chem Int Ed Engl200746305754575617591736
   PubMed Web of Science ®Google Scholar
• GessnerAWaiczRLieskeAPaulkeBMaderKMullerRHNano-particles with decreasing surface hydrophobicities: influence on plasma protein adsorptionInt J Pharm2000196224524910699728
   PubMed Web of Science ®Google Scholar
• NagayamaSOgawaraKFukuokaYHigakiKKimuraTTime-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristicsInt J Pharm20073421–221522117566676
   PubMed Web of Science ®Google Scholar
• PatelBGuptaNAhsanFParticle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcomeEur J Pharm Biopharm20158916317425497488
   PubMed Web of Science ®Google Scholar
• HamidiMAzadiARafieiPPharmacokinetic consequences of PEGy-lationDrug Deliv200613639940917002967
   PubMed Web of Science ®Google Scholar
• AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticlesInt J Pharm20032591–211512712787641
   PubMedGoogle Scholar
• MosqueiraVCLegrandPMorgatJLBiodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and densityPharm Res200118101411141911697466
   PubMed Web of Science ®Google Scholar
• KeumCGNohYWBaekJSPractical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acidInt J Nanomedicine201162225223422114486
   PubMed Web of Science ®Google Scholar
• ScholesPDCoombesAGIllumLDetection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPSJ Control Release199959326127810332059
   PubMed Web of Science ®Google Scholar
• EsmaeiliFAtyabiFDinarvandRPreparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion methodDARU200816196202
   Web of Science ®Google Scholar
• ZhangHCuiWBeiJWangSPreparation of poly(lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solutionPolym Degrad Stab200691919291936
   Web of Science ®Google Scholar
• AsteteCESabliovCMSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polym Ed200617324728916689015
   PubMed Web of Science ®Google Scholar
• KoopaeiMNDinarvandRAminiMDocetaxel immunonano-carriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studiesInt J Nanomedicine201161903191221931485
   PubMed Web of Science ®Google Scholar
• SenthilkumarMMishraPJainNKLong circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of docetaxel to solid tumorsJ Drug Target200816542443518569287
   PubMed Web of Science ®Google Scholar
• EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticlesAnticancer Drugs2010211435219809300
   PubMed Web of Science ®Google Scholar
• MusumeciTVenturaCAGiannoneIPLA/PLGA nanoparticles for sustained release of docetaxelInt J Pharm20063251–217217916887303
   PubMed Web of Science ®Google Scholar
• DhankarRRatheePJainAKHER-2 targeted immunonanoparticles for breast cancer chemotherapyJ Appl Pharm Sci201113132139
   Google Scholar
• VaishampayanUParchmentREJastiBRHussainMTaxanes: an overview of the pharmacokinetics and pharmacodynamicsUrology1999546A suppl222910606281
   PubMedGoogle Scholar
• BakerSDSparreboomAVerweijJClinical pharmacokinetics of docetaxel: recent developmentsClin Pharmacokinet200645323525216509758
   PubMed Web of Science ®Google Scholar
• ClarkeSJRivoryLPClinical pharmacokinetics of docetaxelClin Pharmacokinet19993629911410092957
   PubMed Web of Science ®Google Scholar
• SparreboomAvan TellingenONooijenWJBeijnenJHPreclinical pharmacokinetics of paclitaxel and docetaxelAnticancer Drugs1998911179491787
   PubMedGoogle Scholar
• LoosWJBakerSDVerweijJBoonstraJGSparreboomAClinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteinsClin Pharmacol Ther200374436437114534523
   PubMed Web of Science ®Google Scholar
• YuYTanSZhaoSAntitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification techniqueInt J Nanomedicine201382641265223935362
   PubMed Web of Science ®Google Scholar
• ChuKSHasanWRawalSPlasma, tumor and tissue pharmacokinetics of docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograftNanomedicine20139568669323219874
   PubMed Web of Science ®Google Scholar
• GuptaMChashooGSharmaPRDual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug deliveryMol Pharm201411369771524512060
   PubMed Web of Science ®Google Scholar
• JainSSpandanaGAgrawalAKKushwahVThankiKEnhanced antitumor efficacy and reduced toxicity of docetaxel loaded estradiol functionalized stealth polymeric nanoparticlesMol Pharm201512113871388426375023
   PubMed Web of Science ®Google Scholar
• ZhangYNPoonWTavaresAJMcGilvrayIDChanWCNanoparticle-liver interactions: cellular uptake and hepatobiliary eliminationJ Control Release201624033234826774224
   PubMed Web of Science ®Google Scholar
• ParkJKUtsumiTSeoYECellular distribution of injected PLGA-nanoparticles in the liverNanomedicine20161251365137426961463
   PubMed Web of Science ®Google Scholar
• SarinHPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJ Angiogenes Res201021420701757
   PubMedGoogle Scholar
• RensenPCSliedregtLAFernsMDetermination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivoJ Biol Chem200127640375773758411479285
   PubMed Web of Science ®Google Scholar
• KumariASinglaRGulianiAYadavSKBiodegradable nanoparticles and their in vivo fateYadavKSNanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue RegenerationSingaporeSpringer Singapore20162139
   Google Scholar
• ErnstingMJMurakamiMRoyALiSDFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJ Control Release2013172378279424075927
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• GrefRDombAQuellecPLong-circulating Drug Delivery Systems. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Deliv Rev199516221523325170183
   PubMed Web of Science ®Google Scholar
• HoytRFJrHawkinsJVSt ClairMBKennettJMChapter 2 – mouse physiology A2FoxJGDavissonMTQuimbyFWBartholdSWNewcomerCESmithALThe Mouse in Biomedical Research (Second Edition)BurlingtonAcademic Press200723XVI
   Google Scholar
• WhiteEMechanical modulation of cardiac microtubulesPflugers Arch2011462117718421487691
   PubMedGoogle Scholar
• Aquila-PastirLADiPaolaNRMatteoRGSmediraNGMcCarthyPMMoravecCSQuantitation and distribution of β-tubulin in human cardiac myocytesJ Mol Cell Cardiol200234111513152312431450
   PubMedGoogle Scholar
• JinCBaiLWuHSongWGuoGDouKCytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cellsPharm Res20092671776178419384463
   PubMed Web of Science ®Google Scholar